Question A: The economic benefits of state funding for opioid overdose reversal medication outweigh the economic costs.
Question A: The economic benefits of state funding for opioid overdose reversal medication outweigh the economic costs.
Question A: The economic benefits of state funding for opioid overdose reversal medication outweigh the economic costs.
Question A: The economic benefits of state funding for opioid overdose reversal medication outweigh the economic costs.
| Economist | Institution | Opinion | Confidence | Comment |
|---|---|---|---|---|
| Jonathan Andreas | Bluffton University | Agree | 9 | Nalaxone availability doNaloxone availability does encourage opioid use somewhat, but the elasticity of demand determines whether that causes a net problem and everyone agrees that addictive drugs have highly inelastic demand so naloxone saves lives. |
| Bizuayehu Bedane | Marietta College | Agree | 9 | |
| Kevin Egan | University of Toledo | Strongly Agree | 10 | it is always efficient to subsidize Naloxone and make it more widely available. it is relatively cheap medication with a high probabiity of saving a life. Moreover, we should make Naloxone widely available because it is the right thing to do. |
| Kenneth Fah | Ohio Dominican University | Uncertain | 9 | Additional resources would be needed to transition them into the labor force if drug use leads to unemployment. Significant economic benefits may not be realized if this is not part of a package of treatment. |
| Hasan Faruq | Xavier University | Agree | 8 | |
| Robert Gitter | Ohio Wesleyan University | Strongly Agree | 8 | This is a hard one to answer. Essentially, it is asking if spending X dollars to save Y lives is worth it. That requires some assumptions about the dollar value of a life but I am willing to state that it is worth it. |
| Nancy Haskell | University of Dayton | Agree | 7 | |
| Faria Huq | Lake Erie College | Agree | 8 | As emergency room visits could be lowered, a portion of the burden of the costs that fall on the state could be reduced. Effect on costs in terms of lost productivity would be harder to estimate due to possibility of relapse. |
| Michael Jones | University of Cincinnati | Strongly Agree | 1 | At a cost of just over $40 per medication, the benefit of saving a life would exceed the cost. However, whether the state or the local government should absorb this cost is a different question. |
| Fadhel Kaboub | Denison University | Strongly Agree | 10 | Overdose reversal is often the first step in recovery. The cost of doing nothing about the opioid crisis are much larger than the cost of doing the right thing. |
| Fadhel Kaboub | Denison University | Strongly Agree | 10 | We can't put a price tag on saving someone's life, but we must also recognize the high financial and emotional costs associated with the opioid crisis. Making opioid overdose reversal medication widely accessible massively reduces financial costs. |
| Charles Kroncke | Mount Saint Joseph University | Disagree | 9 | |
| Trevon Logan | Ohio State University | Agree | 9 | |
| Michael Myler | University of Mount Union | Strongly Agree | 10 | For Cost-Benefit Analysis, the federal government's Office of Management and Budget uses $7-$9 million as the value of a human life. If the Ohio program ($13 mil) saves 2 lives, it will be an economic success. |
| Joe Nowakowski | Muskingum University | Strongly Agree | 10 | ~$42 per dose seems like a bargain if it saves a life. a life. |
| Curtis Reynolds | Kent State University | Agree | 8 | |
| Lewis Sage | Baldwin Wallace University | Strongly Agree | 10 | |
| Albert Sumell | Youngstown State University | Strongly Agree | 10 | The alternative is to let opioid addicts die if they overdose. The choice is both ethically and economically obvious. |
| Melissa Thomasson | Miami University | Agree | 8 | |
| Thomas Traynor | Wright State University | Agree | 8 | The specifics of how the funding is targeted matters greatly |
| Ejindu Ume | Miami University | Agree | 9 | |
| Andy Welki | John Carroll University | Agree | 8 | |
| Kathryn Wilson | Kent State University | Agree | 8 | Academic studies of naloxone distribution find a high cost-effectiveness, measured as money spent per quality-adjusted year of life saved. |
| Rachel Wilson | Wittenberg University | Agree | 7 |